HBK Sorce Advisory’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.07M | Sell |
7,047
-53
| -0.7% | -$25.4K | 0.08% | 91 |
|
|
2026
Q1 | $3.3M | Sell |
7,100
-510
| -7% | -$277K | 0.07% | 109 |
|
|
2025
Q4 | $4.13M | Buy |
7,610
+112
| +1% | +$63.3K | 0.09% | 89 |
|
|
2025
Q3 | $3.96M | Sell |
7,498
-1,512
| -17% | -$704K | 0.1% | 86 |
|
|
2025
Q2 | $3.65M | Sell |
9,010
-863
| -9% | -$361K | 0.1% | 92 |
|
|
2025
Q1 | $4.91M | Sell |
9,873
-327
| -3% | -$177K | 0.14% | 66 |
|
|
2024
Q4 | $5.31M | Sell |
10,200
-743
| -7% | -$409K | 0.16% | 63 |
|
|
2024
Q3 | $6.77M | Sell |
10,943
-644
| -6% | -$381K | 0.21% | 49 |
|
|
2024
Q2 | $6.41M | Sell |
11,587
-45
| -0.4% | -$25.8K | 0.22% | 48 |
|
|
2024
Q1 | $6.76M | Sell |
11,632
-437
| -4% | -$245K | 0.24% | 50 |
|
|
2023
Q4 | $6.41M | Sell |
12,069
-1,429
| -11% | -$692K | 0.25% | 45 |
|
|
2023
Q3 | $6.83M | Sell |
13,498
-435
| -3% | -$232K | 0.3% | 44 |
|
|
2023
Q2 | $7.27M | Sell |
13,933
-559
| -4% | -$302K | 0.31% | 43 |
|
|
2023
Q1 | $8.35M | Sell |
14,492
-18,320
| -56% | -$10.3M | 0.38% | 32 |
|
|
2022
Q4 | $18.1M | Buy |
32,812
+17,090
| +109% | +$9.06M | 0.49% | 30 |
|
|
2022
Q3 | $7.97M | Buy |
15,722
+2,533
| +19% | +$1.42M | 0.53% | 24 |
|
|
2022
Q2 | $7.17M | Sell |
13,189
-419
| -3% | -$231K | 0.53% | 23 |
|
|
2022
Q1 | $8.04M | Sell |
13,608
-467
| -3% | -$268K | 0.44% | 36 |
|
|
2021
Q4 | $9.39M | Buy |
14,075
+761
| +6% | +$475K | 0.48% | 32 |
|
|
2021
Q3 | $7.61M | Buy |
13,314
+351
| +3% | +$193K | 0.42% | 34 |
|
|
2021
Q2 | $6.54M | Sell |
12,963
-143
| -1% | -$67.5K | 0.36% | 36 |
|
|
2021
Q1 | $5.98M | Buy |
13,106
+2,979
| +29% | +$1.42M | 0.36% | 38 |
|
|
2020
Q4 | $4.72M | Buy |
10,127
+345
| +4% | +$162K | 0.29% | 48 |
|
|
2020
Q3 | $4.32M | Buy |
9,782
+464
| +5% | +$192K | 0.31% | 46 |
|
|
2020
Q2 | $3.38M | Buy |
9,318
+311
| +3% | +$104K | 0.25% | 61 |
|
|
2020
Q1 | $2.55M | Buy |
9,007
+320
| +4% | +$101K | 0.25% | 65 |
|
|
2019
Q4 | $2.82M | Buy |
8,687
+79
| +0.9% | +$24K | 0.25% | 80 |
|
|
2019
Q3 | $2.51M | Buy |
8,608
+276
| +3% | +$79K | 0.24% | 83 |
|
|
2019
Q2 | $2.45M | Buy |
8,332
+165
| +2% | +$45.4K | 0.24% | 86 |
|
|
2019
Q1 | $2.23M | Buy |
8,167
+161
| +2% | +$40.1K | 0.22% | 89 |
|
|
2018
Q4 | $1.79M | Buy |
8,006
+879
| +12% | +$206K | 0.2% | 98 |
|
|
2018
Q3 | $1.74M | Sell |
7,127
-159
| -2% | -$36.6K | 0.2% | 87 |
|
|
2018
Q2 | $1.51M | Buy |
7,286
+1,459
| +25% | +$310K | 0.17% | 95 |
|
|
2018
Q1 | $1.2M | Buy |
5,827
+142
| +2% | +$29.8K | 0.15% | 103 |
|
|
2017
Q4 | $1.08M | Buy |
5,685
+158
| +3% | +$30.3K | 0.13% | 118 |
|
|
2017
Q3 | $1.05M | Buy |
5,527
+72
| +1% | +$13K | 0.16% | 93 |
|
|
2017
Q2 | $952K | Buy |
+5,455
| New | +$916K | 0.15% | 97 |
|
|
2017
Q1 | – | Sell |
-4,812
| Closed | -$735K | – | 410 |
|
|
2016
Q4 | $679K | Sell |
4,812
-26
| -0.5% | -$3.83K | 0.12% | 134 |
|
|
2016
Q3 | $770K | Buy |
4,838
+122
| +3% | +$18.8K | 0.15% | 101 |
|
|
2016
Q2 | $697K | Buy |
4,716
+396
| +9% | +$58.4K | 0.15% | 104 |
|
|
2016
Q1 | $612K | Buy |
4,320
+338
| +8% | +$45.3K | 0.14% | 106 |
|
|
2015
Q4 | $565K | Buy |
3,982
+446
| +13% | +$59.5K | 0.15% | 104 |
|
|
2015
Q3 | $432K | Buy |
3,536
+1,207
| +52% | +$157K | 0.14% | 105 |
|
|
2015
Q2 | $302K | Hold |
2,329
| – | – | 0.1% | 134 |
|
|
2015
Q1 | $313K | Sell |
2,329
-12
| -0.5% | -$1.55K | 0.11% | 128 |
|
|
2014
Q4 | $293K | Buy |
+2,341
| New | +$285K | 0.1% | 134 |
|
Other funds holding TMO
HBK Sorce Advisory's TMO Position: Q2 2026 in Review
HBK Sorce Advisory reduced its Thermo Fisher Scientific (TMO) stake by 0.75% in Q2 2026, selling an estimated $25.4K and leaving 7,047 shares worth $4.07M. The position accounts for 0.08% of the portfolio, ranked #91.
HBK Sorce Advisory first reported a position in TMO in Q4 2014 and has held it in 46 quarters since. The position peaked at $18.1M in Q4 2022. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- HBK Sorce Advisory held 7,047 shares of Thermo Fisher Scientific worth $4.07M as of Q2 2026.
- HBK Sorce Advisory sold 53 Thermo Fisher Scientific shares in Q2 2026, an estimated $25.4K.
- Thermo Fisher Scientific made up 0.08% of HBK Sorce Advisory's portfolio in Q2 2026, its #91 holding.
- HBK Sorce Advisory first reported a position in Thermo Fisher Scientific in Q4 2014 and has held it in 46 quarters since.
- HBK Sorce Advisory's Thermo Fisher Scientific position peaked at $18.1M in Q4 2022.
- 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on HBK Sorce Advisory's 13F filing for Q2 2026, filed 6 Aug 2026.